An association between decreased estimated glomerular filtration rate and arterial stiffness

Internal Medicine

Volumn 47, Issue 7, 2008, Pages 593-598

  Kawamoto, Ryuichi ^a   Kohara, Katsuhiko ^b   Tabara, Yasuharu ^b   Miki, Tetsuro ^b   Ohtsuka, Nobuyuki ^a   Kusunoki, Tomo ^a   Yorimitsu, Nobukazu ^a  

^a Nomura Municipal Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; CKD; eGFR; Renal function; Risk factor

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANKLE; ARTERIAL STIFFNESS; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXPLANATORY VARIABLE; FEMALE; GLOMERULUS FILTRATION RATE; HEART; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NEUROLOGIC DISEASE; PERIODIC MEDICAL EXAMINATION; PULSE WAVE; RANDOMIZATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR RESISTANCE;

AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VASCULAR RESISTANCE;

EID: 44849095547     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0825     Document Type: Article

References (25)

1. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005.
2. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Chn Exp Nephrol 11: 156-163, 2007.
3. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44: 198-206, 2004.
4. Meisinger C, Doring A, Lowel H. KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 27: 1245-1250, 2006.
5. Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 39: 735-738, 2002.
6. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T. Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 27: 471-477, 2004.
7. Schillaci G, Pirro M, Mannarino MR, et al. Relation between renal function within the normal range and central and peripheral arterial stifness in hypertension. Hypertension 48: 616-621, 2006.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
9. Levey AS, Coresh J, Greene T, et al. Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006.
10. Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 11: 41-50, 2007.
11. National Kidney Foundation. K/DOQI clinical practice guideline to define chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 [Suppl 2]: S1-S266, 2002.
12. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56: 2214-2219, 1999.
13. Tsubakimoto A, Saito I, Mannami T, et al. Impact of metabolic syndrome on brachial-ankle pulse wave velocity in Japanese. Hypertens Res 29: 29-37, 2006.
14. Kim EJ, Park CG, Park JS, et al. Relationship between blood pressure parameters and pulse wave velocity in normotensive and hypertensive subjects: invasive study. J Hum Hypertens 21: 141-148, 2007.
15. Watanabe S, Okura T, Kitami Y, Hiwada K. Carotid hemodynamic alterations in hypertensive patients with insulin resistance. Am J Hypertens 15: 851-856, 2002.
16. Seo HS, Kang TS, Park S, et al. Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens Res 28: 945-951, 2005.
17. Sarafidis PA, Lasaridis AN, Nilsson PM, et al. Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. J Hypertens 22: 1769-1777, 2004.
18. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Mod 334: 374-381, 1996.
19. Safar ME. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens 23: 673-681, 2005.
20. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002.
21. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426, 2001.
22. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis, JAMA 288: 2015-2022, 2002.
23. Drueke T, Witko-Sarsat V, Massy Z, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212-2217, 2002.
24. Honda H, Qureshi AR, Heimburger O, et al. Semin albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148, 2006.
25. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16: 763-773, 2005.